CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-27. Amounts in USD.

Revenue Quarterly

0 400M 800M 1.2B Q3 '21: 895.9M Q4 '21: 905M Q1 '22: 913.9M Q2 '22: 973.1M Q3 '22: 989.2M Q4 '22: 1.1B Q2 '23: 1B Q3 '23: 1.1B Q3 '23: 1B Q4 '23: 1B Q1 '24: 1B Q2 '24: 1B Q3 '24: 1B Q4 '24: 1B Q1 '25: 984.2M Q2 '25: 1B Q3 '25: 1B Q4 '25: 994.2M Q1 '26: 995.8M Q2 '26: 1B Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 150M 300M 450M Q1 '16: 140.8M Q2 '16: 169.7M Q3 '16: 156.3M Q4 '16: 179.9M Q2 '17: 171.4M Q3 '17: 185.3M Q3 '17: 176.8M Q4 '17: 167.4M Q1 '18: 181.5M Q2 '18: 216M Q3 '18: 216.2M Q4 '18: 226.4M Q1 '19: 211.8M Q2 '19: 238.1M Q3 '19: 246.1M Q4 '19: 262.3M Q1 '20: 252.1M Q2 '20: 232.2M Q3 '20: 289.3M Q4 '20: 300M Q2 '16 Q2 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Operating Income Quarterly

0 70M 140M 210M Q1 '21: 123.7M Q2 '21: 137.6M Q3 '21: 155.8M Q4 '21: 172.8M Q1 '22: 148.8M Q2 '22: 187.4M Q3 '22: 151M Q4 '22: 163.8M Q2 '23: 167.9M Q3 '23: 164.9M Q3 '23: 151.5M Q4 '23: 132.9M Q1 '24: 126M Q2 '24: 151.7M Q3 '24: 117.4M Q1 '25: 74.7M Q2 '25: 100.1M Q3 '25: 133.8M Q1 '26: 119.9M Q2 '26: 119.9M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q2 '25 Q2 '26

Net Income Quarterly

-300M -200M -100M 0 100M 200M 300M Q2 '21: 88.4M Q3 '21: 103.4M Q4 '21: 137.6M Q1 '22: 93M Q2 '22: 109.3M Q3 '22: 96.5M Q4 '22: 187.4M Q2 '23: 103.1M Q3 '23: 97M Q3 '23: 87.4M Q4 '23: 187.1M Q1 '24: 73M Q2 '24: 94.1M Q3 '24: 69.7M Q1 '25: 25.5M Q2 '25: 52.3M Q3 '25: 54.4M Q4 '25: -276.6M Q1 '26: -14.8M Q2 '26: -1.5M Q3 '21 Q2 '22 Q2 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 250M 500M 750M Q2 '23: 651.7M Q3 '23: 661M Q3 '23: 664.8M Q1 '24: 666.7M Q2 '24: 672.4M Q3 '24: 660.7M Q2 '23 Q3 '23 Q3 '23 Q1 '24 Q2 '24 Q3 '24

Operating Cash Flow Quarterly

0 90M 180M 270M Q3 '21: 174.7M Q4 '21: 229.3M Q1 '22: 102.6M Q2 '22: 149.5M Q3 '22: 132.8M Q4 '22: 234.8M Q2 '23: 109.4M Q3 '23: 148.1M Q3 '23: 205.4M Q4 '23: 220.9M Q1 '24: 129.9M Q2 '24: 193.5M Q3 '24: 251.8M Q4 '24: 159.4M Q1 '25: 171.7M Q2 '25: 204.6M Q3 '25: 213.8M Q4 '25: 147.5M Q1 '26: 41.1M Q2 '26: 179.7M Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-80M 0 80M 160M 240M Q3 '21: 119.2M Q4 '21: 130.5M Q1 '22: 22.2M Q2 '22: 66.6M Q3 '22: 60.4M Q4 '22: 145.7M Q2 '23: 2.5M Q3 '23: 80.7M Q3 '23: 139.5M Q4 '23: 142.6M Q1 '24: 50.7M Q2 '24: 154M Q3 '24: 213.1M Q4 '24: 83.7M Q1 '25: 112.4M Q2 '25: 169.3M Q3 '25: 178.2M Q4 '25: 58.6M Q1 '26: -14.8M Q2 '26: 148.6M Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 50M Q2 '20: 50.2M Q3 '20: 50.7M Q1 '21: 51.1M Q2 '21: 51.3M Q3 '21: 51.6M Q1 '22: 51.3M Q2 '22: 51.3M Q3 '22: 51.3M Q2 '23: 51.4M Q3 '23: 51.5M Q3 '23: 51.6M Q1 '24: 51.8M Q2 '24: 51.8M Q3 '24: 51.6M Q1 '25: 50.9M Q2 '25: 49.3M Q3 '25: 49.4M Q1 '26: 49M Q2 '26: 48M Q2 '20 Q2 '21 Q2 '22 Q3 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.00 -3.50 0.00 3.50 7.00 10.50 Q3 '20: 6.00 Q4 '20: 7.20 Q1 '21: 7.38 Q2 '21: 7.76 Q3 '21: 7.74 Q4 '21: 7.60 Q1 '22: 8.21 Q2 '22: 8.62 Q3 '22: 8.49 Q4 '22: 9.47 Q2 '23: 9.67 Q3 '23: 9.43 Q3 '23: 9.24 Q4 '23: 9.23 Q1 '24: 8.52 Q2 '24: 8.37 Q3 '24: 8.01 Q4 '25: -2.90 Q1 '26: -3.70 Q2 '26: -4.79 Q4 '20 Q3 '21 Q2 '22 Q2 '23 Q4 '23 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.